DCCR benefits for PWS confirmed in Magel2 deficient mice with improved endurance capacity
FEB 2018 - Diazoxide Choline Controlled Release (DCCR) is currently being developed by Soleno Therapeutics following a successful phase 2 trial in PWS patients which observed improvements in hyperphagia, a reduction of body fat and increase in lean body mass. They…